Bicocca Open Archive

Logo unimib boa
BOMBELLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.132
AS - Asia 7.335
EU - Europa 6.615
SA - Sud America 1.128
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 28.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.818
SG - Singapore 2.997
CN - Cina 1.833
HK - Hong Kong 1.244
IT - Italia 1.229
RU - Federazione Russa 1.225
DE - Germania 1.131
BR - Brasile 903
SE - Svezia 856
IE - Irlanda 706
VN - Vietnam 522
UA - Ucraina 442
GB - Regno Unito 347
CA - Canada 218
FI - Finlandia 174
IN - India 160
FR - Francia 128
KR - Corea 128
AR - Argentina 102
ID - Indonesia 75
NL - Olanda 75
BD - Bangladesh 68
MX - Messico 62
ZA - Sudafrica 62
AT - Austria 55
TR - Turchia 55
DK - Danimarca 49
PL - Polonia 46
EC - Ecuador 44
JP - Giappone 44
IQ - Iraq 38
ES - Italia 29
CZ - Repubblica Ceca 22
CO - Colombia 21
UZ - Uzbekistan 21
BE - Belgio 20
IR - Iran 17
PK - Pakistan 16
KE - Kenya 15
RO - Romania 15
AE - Emirati Arabi Uniti 13
CL - Cile 13
SA - Arabia Saudita 13
VE - Venezuela 13
PY - Paraguay 12
EU - Europa 11
MA - Marocco 11
PE - Perù 11
MY - Malesia 10
CH - Svizzera 9
LT - Lituania 9
AU - Australia 8
AZ - Azerbaigian 8
PA - Panama 8
PH - Filippine 7
JO - Giordania 6
KH - Cambogia 6
LK - Sri Lanka 6
PT - Portogallo 6
TH - Thailandia 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
LV - Lettonia 5
UY - Uruguay 5
BB - Barbados 4
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
NP - Nepal 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BJ - Benin 3
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
CM - Camerun 2
GE - Georgia 2
HR - Croazia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
OM - Oman 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
Totale 28.338
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.953
Singapore 1.643
Hong Kong 1.240
Ashburn 1.137
Woodbridge 944
Fairfield 824
Houston 776
Chandler 708
Frankfurt am Main 699
Dublin 668
Wilmington 489
Jacksonville 466
Dearborn 435
New York 434
Seattle 375
Milan 371
Beijing 342
Santa Clara 320
Hefei 294
Cambridge 268
Princeton 244
Dallas 230
Los Angeles 199
Ho Chi Minh City 131
Hanoi 130
Nanjing 130
Seoul 123
Altamura 122
Moscow 122
Lawrence 117
Shanghai 115
Chicago 105
Buffalo 92
Munich 90
São Paulo 82
Lachine 79
San Diego 77
Guangzhou 59
The Dalles 57
Nanchang 52
Helsinki 51
Jakarta 47
Boardman 45
London 45
Toronto 44
Andover 43
Council Bluffs 42
Warsaw 39
Dong Ket 38
Fremont 38
Rome 38
Tianjin 38
Hebei 36
Rio de Janeiro 35
Tokyo 35
Brooklyn 34
Shenyang 34
Salt Lake City 33
Vienna 32
Falls Church 31
Lissone 31
Johannesburg 29
Turku 29
Montreal 28
Atlanta 27
Changsha 27
Nuremberg 26
Chennai 25
Monza 25
Phoenix 25
Denver 24
Ottawa 24
Haiphong 22
Jiaxing 22
Amsterdam 21
Jinan 21
Kunming 21
Ningbo 21
Stockholm 21
Columbus 20
Manchester 20
Nürnberg 20
Orem 20
Da Nang 19
Zhengzhou 19
Brno 18
Norwalk 18
Tashkent 18
Porto Alegre 17
Brussels 16
New Delhi 16
Guayaquil 15
Poplar 15
Dhaka 14
Düsseldorf 14
Elk Grove Village 14
Hangzhou 14
Lentate sul Seveso 14
Mexico City 14
Philadelphia 14
Totale 18.338
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 387
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 366
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 317
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 311
Differing associations for sport versus occupational physical activity and cardiovascular risk 300
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 293
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 283
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 269
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 266
The Pamela study: main findings and perspectives 263
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 262
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 259
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 259
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 254
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 252
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 250
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 247
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 246
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 243
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 240
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 237
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 236
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 236
Combined effects of hypertension and hypercholesterolemia on radial artery function 232
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 232
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 226
The association between 24-h blood pressure patterns and left ventricular mechanics 226
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 225
Role of ambulatory blood pressure monitoring in resistant hypertension 224
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 223
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 222
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 219
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 218
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 218
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 216
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 215
New-onset left atrial enlargement in a general population 215
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 214
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 214
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 213
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 212
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 211
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 210
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 210
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 208
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 207
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 207
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 206
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 206
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 204
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 204
Diurnal blood pressure variation and sympathetic activity 201
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 198
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 197
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 197
Should white-coat hypertension in diabetes be treated? Pro 196
HIV and metabolic syndrome - A comparison with the general population 195
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 194
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 194
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 194
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 193
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 193
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 193
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 190
The Pamela Study: Old and New Findings 186
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 186
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 186
Diagnosis and management of patients with white-coat and masked hypertension 185
Importance of uric acid threshold in its correlation with metabolic syndrome 185
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 184
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 183
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 182
Predictive value of different indices of blood pressure variability on 182
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 181
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 180
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 179
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 176
Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke 175
Long-term risk of sustained hypertension in white-coat or masked hypertension 175
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 175
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 173
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 173
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 170
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 169
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients 168
Ambulatory blood pressure in air traffic controllers 168
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 168
Do reverse dippers have the highest risk of right ventricular remodeling? 168
Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study 167
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 166
Metabolic Syndrome is Related to Vascular Structural Alterations But Not to Functional one both in Hypertensives and Healthy Subjects in Selected abstracts from the XXXVIII National Congress of the Italian Society of Hypertension (SIIA) 164
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 163
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 163
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 163
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 156
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 156
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. 155
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) 154
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension 154
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 153
Totale 21.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.411 0 0 0 0 0 203 219 225 185 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20256.152 319 718 285 281 476 170 269 274 570 858 737 1.195
2025/20266.601 1.463 858 1.083 1.505 1.539 153 0 0 0 0 0 0
Totale 28.996